# CORRESP — Jade Biosciences, Inc.  (JBIO)  (CIK 0001798749)

> <strong>Jade Biosciences, Inc.  (JBIO)  (CIK 0001798749) → SEC staff</strong> · filed 2025-12-23 · ticker JBIO · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001193125-25-330829
- **Form:** CORRESP
- **Filer:** Jade Biosciences, Inc.  (JBIO)  (CIK 0001798749)
- **CIK:** 0001798749
- **Ticker:** JBIO
- **Filed:** 2025-12-23
- **SIC industry:** 2834
- **HQ:** Waltham, MA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1798749/000119312525330829/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1798749&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Jade Biosciences, Inc.  (JBIO)  (CIK 0001798749)

- CORRESP — 2026-05-13 — /comment-letter/0001193125-26-221571
- CORRESP — 2026-05-13 — /comment-letter/0001193125-26-221557
- UPLOAD — 2026-05-13 — /comment-letter/0000000000-26-004877
- UPLOAD — 2026-05-13 — /comment-letter/0000000000-26-004876
- UPLOAD — 2025-12-23 — /comment-letter/0000000000-25-011803

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Jade Biosciences, Inc.  (JBIO)  (CIK 0001798749) (CIK 0001798749), filed 2025-12-23, accession 0001193125-25-330829. Retrieved via MORVS 2026-11-14 from https://api.morvs.ai/comment-letter/0001193125-25-330829.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*